STEVEN GILLIS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEVEN GILLIS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVEN GILLIS. STEVEN GILLIS is Director in VBI VACCINES INC. ($VBIV) and CEO in CORIXA CORP ($CRXA) and Director in bluebird bio, Inc. ($BLUE) and Director in VBI Vaccines Inc/BC ($VBIV) and Director in PHASERX, INC. ($PZRX) and Director in Pulmatrix, Inc. ($PULM) and Director in Codiak BioSciences, Inc. ($CDAK) and Director in Homology Medicines, Inc. ($FIXX).
Latest Insider Trading Transactions of STEVEN GILLIS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BLUE, CDAK, CRXA, FIXX, PZRX, PULM, VBIV, VBIV
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | CDAK | Codiak BioSciences ... | GILLIS STEVEN | Director | Option Exercise | A | 24.13 | 10,000 | 241,300 | 10,000 | |
| Jan 29 2021 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Option Exercise | A | 3.15 | 100,000 | 315,000 | 100,000 | |
| Oct 15 2020 | CDAK | Codiak BioSciences ... | GILLIS STEVEN | Director | Option Exercise | A | 15.00 | 10,000 | 150,000 | 10,000 | |
| Sep 01 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 1.28 | 10,000 | 12,800 | 10,000 | |
| Sep 01 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | D | 1.28 | 10,000 | 12,800 | 0 | |
| Sep 01 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 1.54 | 15,000 | 23,100 | 15,000 | |
| Sep 01 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | D | 1.54 | 15,000 | 23,100 | 0 | |
| Sep 01 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 1.06 | 15,000 | 15,900 | 15,000 | |
| Sep 01 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | D | 1.06 | 15,000 | 15,900 | 0 | |
| Sep 01 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 4.68 | 12,400 | 58,032 | 12,400 | |
| Sep 01 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | D | 4.68 | 12,400 | 58,032 | 0 | |
| Sep 01 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 27.80 | 440 | 12,232 | 440 | |
| Sep 01 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | D | 27.80 | 440 | 12,232 | 0 | |
| Sep 01 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 28.00 | 880 | 24,640 | 880 | |
| Sep 01 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | D | 28.00 | 880 | 24,640 | 0 | |
| Sep 01 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 110.00 | 111 | 12,210 | 111 | |
| Sep 01 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | D | 110.00 | 111 | 12,210 | 0 | |
| Sep 01 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 118.00 | 1,771 | 208,978 | 1,771 | |
| Sep 01 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | D | 118.00 | 1,771 | 208,978 | 0 | |
| Jun 12 2020 | FIXX | Homology Medicines ... | GILLIS STEVEN | Director | Option Exercise | A | 16.32 | 18,000 | 293,760 | 18,000 | |
| Apr 06 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 1.28 | 10,000 | 12,800 | 10,000 | |
| Jan 24 2020 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Option Exercise | A | 1.46 | 350,000 | 511,000 | 350,000 | |
| Jan 13 2020 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 1.54 | 15,000 | 23,100 | 15,000 | |
| Sep 23 2019 | VBIV | VBI VACCINES INC. | GILLIS STEVEN | Director | Buy | P | 0.50 | 10,000,000 | 5,000,000 | 13,026,057 | 3 M to 13 M (+330.46 %) |
| Sep 23 2019 | VBIV | VBI VACCINES INC. | GILLIS STEVEN | Director | Buy | P | 0.50 | 10,000,000 | 5,000,000 | 13,026,057 | 3 M to 13 M (+330.46 %) |
| Jun 18 2019 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Option Exercise | M | 0.00 | 18,750 | 0 | 0 | |
| Jun 18 2019 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Buy | M | 0.00 | 18,750 | 0 | 84,416 | 65.7 K to 84.4 K (+28.55 %) |
| Jun 10 2019 | FIXX | Homology Medicines ... | GILLIS STEVEN | Director | Option Exercise | A | 19.51 | 15,580 | 303,966 | 15,580 | |
| May 20 2019 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 1.06 | 15,000 | 15,900 | 15,000 | |
| Feb 04 2019 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Option Exercise | A | 1.67 | 300,000 | 501,000 | 300,000 | |
| Jun 25 2018 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Option Exercise | M | 0.00 | 18,750 | 0 | 18,750 | |
| Jun 25 2018 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Buy | M | 0.00 | 18,750 | 0 | 65,666 | 46.9 K to 65.7 K (+39.97 %) |
| Jun 06 2018 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 0.47 | 124,000 | 58,032 | 124,000 | |
| Apr 05 2018 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | P | 0.75 | 1,150,000 | 862,500 | 1,150,000 | |
| Apr 05 2018 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | P | 0.65 | 1,150,000 | 747,500 | 1,150,000 | |
| Apr 05 2018 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Buy | P | 0.00 | 1,150,000 | 0 | 3,436,456 | 2.3 M to 3.4 M (+50.30 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | GILLIS STEVEN | Director | Option Exercise | C | 0.00 | 1,385,457 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | GILLIS STEVEN | Director | Option Exercise | C | 0.00 | 4,683,238 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | GILLIS STEVEN | Director | Buy | C | 0.00 | 6,068,695 | 0 | 6,068,695 | 0 to 6.1 M |
| Mar 29 2018 | FIXX | Homology Medicines ... | GILLIS STEVEN | Director | Option Exercise | A | 16.00 | 31,160 | 498,560 | 31,160 | |
| Jan 25 2018 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Option Exercise | A | 4.19 | 100,000 | 419,000 | 100,000 | |
| Oct 31 2017 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Buy | P | 3.05 | 300,000 | 915,000 | 3,026,057 | 2.7 M to 3 M (+11.00 %) |
| Jun 16 2017 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Option Exercise | M | 0.00 | 18,750 | 0 | 37,500 | |
| Jun 16 2017 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Buy | M | 0.00 | 18,750 | 0 | 46,916 | 28.2 K to 46.9 K (+66.57 %) |
| May 30 2017 | PZRX | PHASERX, INC. | GILLIS STEVEN | Director | Option Exercise | A | 1.08 | 14,000 | 15,119 | 14,000 | |
| Mar 31 2017 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Option Exercise | A | 3.79 | 15,000 | 56,850 | 15,000 | |
| Mar 31 2017 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Option Exercise | M | 2.50 | 6,377 | 15,943 | 0 | |
| Mar 31 2017 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Buy | M | 2.50 | 6,377 | 15,943 | 28,166 | 21.8 K to 28.2 K (+29.27 %) |
| Mar 22 2017 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 2.78 | 4,400 | 12,232 | 4,400 | |
| Jun 02 2016 | PZRX | PHASERX, INC. | GILLIS STEVEN | Director | Option Exercise | A | 5.08 | 31,023 | 157,597 | 31,023 | |
| May 25 2016 | PZRX | PHASERX, INC. | GILLIS STEVEN | Director | Option Exercise | A | 1.81 | 9,385 | 16,987 | 9,385 | |
| May 25 2016 | PZRX | PHASERX, INC. | GILLIS STEVEN | Director | Buy | P | 5.00 | 1,000,000 | 5,000,000 | 2,854,222 | 1.9 M to 2.9 M (+53.93 %) |
| May 25 2016 | PZRX | PHASERX, INC. | GILLIS STEVEN | Director | Sell | S | 0.01 | 195,156 | 1,952 | 1,854,222 | 2 M to 1.9 M (-9.52 %) |
| May 25 2016 | PZRX | PHASERX, INC. | GILLIS STEVEN | Director | Sell | S | 0.01 | 484,903 | 4,849 | 2,049,378 | 2.5 M to 2 M (-19.13 %) |
| Feb 25 2016 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 2.80 | 8,800 | 24,640 | 8,800 | |
| Aug 17 2015 | VBIV | VBI VACCINES INC. | GILLIS STEVEN | Director | Grant | A | 2.10 | 650,000 | 1,365,000 | 4,047,830 | 3.4 M to 4 M (+19.13 %) |
| Aug 05 2015 | VBIV | VBI VACCINES INC. | GILLIS STEVEN | Director | Option Exercise | A | 2.56 | 70,000 | 179,200 | 191,089 | |
| Jul 30 2015 | BLUE | bluebird bio, Inc. | GILLIS STEVEN | Director | Buy | J | 0.00 | 5,126 | 0 | 18,633 | 13.5 K to 18.6 K (+37.95 %) |
| Jul 30 2015 | BLUE | bluebird bio, Inc. | GILLIS STEVEN | Director | Sell | J | 0.00 | 233,000 | 0 | 90,675 | 323.7 K to 90.7 K (-71.99 %) |
| Jun 29 2015 | BLUE | bluebird bio, Inc. | GILLIS STEVEN | Director | Buy | J | 0.00 | 11,837 | 0 | 13,507 | 1.7 K to 13.5 K (+708.80 %) |
| Jun 29 2015 | BLUE | bluebird bio, Inc. | GILLIS STEVEN | Director | Sell | J | 0.00 | 538,076 | 0 | 323,675 | 861.8 K to 323.7 K (-62.44 %) |
| Jun 25 2015 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 11.00 | 1,108 | 12,188 | 1,108 | |
| Jun 17 2015 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 11.80 | 17,710 | 208,978 | 17,710 | |
| Jun 17 2015 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 7.56 | 797,506 | 6,031,139 | 797,506 | |
| Jun 17 2015 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Buy | P | 6.88 | 72,750 | 500,156 | 2,286,456 | 2.2 M to 2.3 M (+3.29 %) |
| Jun 17 2015 | PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Grant | A | 0.00 | 2,213,706 | 0 | 2,213,706 | 0 to 2.2 M |
| Jun 08 2015 | BLUE | bluebird bio, Inc. | GILLIS STEVEN | Director | Option Exercise | A | 184.98 | 7,500 | 1,387,350 | 7,500 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 17.00 | 10,938 | 185,946 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 15.07 | 219 | 3,300 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 15.07 | 5,031 | 75,817 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 13.45 | 109,231 | 1,469,157 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 9.50 | 15,726 | 149,397 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 8.69 | 51,957 | 451,376 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 6.41 | 7,285 | 46,697 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 6.04 | 64,525 | 389,731 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 5.70 | 138,487 | 789,376 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | M | 3.95 | 149,999 | 592,496 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 17.00 | 4,062 | 69,054 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 15.07 | 5,250 | 79,118 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 13.45 | 5,769 | 77,593 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 9.50 | 9,274 | 88,103 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 9.50 | 12,750 | 121,125 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 8.69 | 21,543 | 187,155 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 6.41 | 7,715 | 49,453 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 6.04 | 25,475 | 153,869 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | D | 5.70 | 11,513 | 65,624 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | M | 3.95 | 1 | 4 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | M | 0.99 | 17,171 | 16,999 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Sell | D | 4.40 | 369,639 | 1,626,412 | 0 | 369.6 K to 0 (-100.00 %) |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Grant | A | 2.61 | 160 | 418 | 369,639 | 369.5 K to 369.6 K (+0.04 %) |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Buy | D | 4.40 | 149,999 | 659,996 | 369,479 | 219.5 K to 369.5 K (+68.34 %) |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Buy | M | 3.95 | 149,999 | 592,496 | 519,478 | 369.5 K to 519.5 K (+40.60 %) |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Buy | M | 0.99 | 17,171 | 16,999 | 369,479 | 352.3 K to 369.5 K (+4.87 %) |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Buy | M | 3.95 | 1 | 4 | 352,308 | 352.3 K to 352.3 K (0.00 %) |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Grant | A | 2.61 | 3,343 | 8,724 | 352,307 | 349 K to 352.3 K (+0.96 %) |
| Jul 14 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Grant | A | 3.09 | 808 | 2,500 | 348,964 | 348.2 K to 349 K (+0.23 %) |
| Jan 03 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | A | 3.95 | 149,999 | 592,496 | 149,999 | |
| Jan 03 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | A | 3.95 | 1 | 4 | 1 | |
| Jan 03 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Option Exercise | M | 0.33 | 36,363 | 12,000 | 0 | |
| Jan 03 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Buy | M | 0.33 | 36,363 | 12,000 | 348,156 | 311.8 K to 348.2 K (+11.66 %) |
| Jan 03 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Grant | A | 3.54 | 707 | 2,500 | 311,793 | 311.1 K to 311.8 K (+0.23 %) |
| Jan 03 2005 | CRXA | CORIXA CORP | GILLIS STEVEN | CEO | Grant | A | 3.97 | 630 | 2,501 | 311,086 | 310.5 K to 311.1 K (+0.20 %) |
Page: 1